Markets
BSE See NSE See 47,705.80
-243.62 (-0.51%)
Recommendation from Diversified Sector

Recommendation from Diversified Sector

Print

This column gives you scrip chosen by the research team during the fortnight that is fundamentally strong and expected to give good capital appreciation over a time period of 1 year. 

 

To read the entire article, you must be a DSIJ magazine subscriber.

 
 

 

Comments are only visible to subscribers.

DSIJ Mindshare

Caplin Point subsidiary gets USFDA approval for Milrinone Lactate injection

Ganesh V / Article rating: 4.5

Caplin Point Laboratories Limited announced on Monday after the market hours that its subsidiary company, Caplin Steriles Limited, has been granted final approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Milrinone Lactate injection. 

1345Last